For: | Lin J, Lin ZQ, Zheng SC, Chen Y. Immune checkpoint inhibitor-associated gastritis: Patterns and management. World J Gastroenterol 2024; 30(14): 1941-1948 [PMID: 38681126 DOI: 10.3748/wjg.v30.i14.1941] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i14/1941.htm |
Number | Citing Articles |
1 |
Ying-Fang Deng, Xian-Shu Cui, Liang Wang. Reconceptualization of immune checkpoint inhibitor-associated gastritis. World Journal of Gastroenterology 2024; 30(36): 4031-4035 doi: 10.3748/wjg.v30.i36.4031
|
2 |
Bo-Tong Ma, Li-Xuan Sang, Bing Chang. Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis. World Journal of Gastroenterology 2024; 30(24): 3123-3125 doi: 10.3748/wjg.v30.i24.3123
|
3 |
Carolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, Krishnavathana Varatharajalu, Anusha Thomas, Yinghong Wang. Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management. Immunotherapy 2025; 17(4): 293 doi: 10.1080/1750743X.2025.2473305
|
4 |
Li-Li Yu, Zhi-Lin He, Xin-Lai Qian. Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies. World Journal of Gastroenterology 2024; 30(24): 3120-3122 doi: 10.3748/wjg.v30.i24.3120
|